iGMDRD127
Canonical SMILES: CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C
InChI: InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1
InChI Key: BTIHMVBBUGXLCJ-OAHLLOKOSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NameSeliciclib CHEMBLCHEMBL14762 Pubchem CID160355 DRUGBANK IDDB06195 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
Antineoplastic AgentsCOX InhibitorsCOX-2 InhibitorsCyclin-Dependent Kinases, antagonists & inhibitorsEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 2-RingProtein Kinase InhibitorsDrug Targets:
CDK1 (P06493)CDK2 (P24941)MAPK3 (P27361)MAPK1 (P28482)CDK7 (P50613)CDK9 (P50750)CSNK1E (P49674)Drug Pathways:
Cell cycleDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Seliciclib
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |